Sales of Amjevita, Amgen's new biosimilar version of AbbVie's blockbuster arthritis drug Humira, canadian pharmacy worldwide shipping rose 30% to $152 million, but sales of cancer drug Lumakras fell 31% to $52 million and sales of arthritis drug Enbrel fell 6% to $1.1 billion.